Cresset Asset Management, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $828,000 - $910,404
-1,800 Reduced 85.71%
300 $139,000
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $1.57 Million - $1.94 Million
-4,000 Reduced 65.57%
2,100 $984,000
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $2.49 Million - $2.72 Million
6,100 New
6,100 $2.55 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $45 Million - $48.3 Million
133,200 New
133,200 $46.3 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email